A significant breakthrough in cancer research is arising with the use of VHH fragments to re-engage dysfunctional p53. This vital tumor protector protein is frequently inactivated in many kinds of malignancies, https://bookmarkcitizen.com/story21931698/mini-antibodies-restore-the-p53-protein-a-promising-approach-for-tumor-therapy